You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study

Article metrics

Article menu

Download PDFPDF

XML
Clinical and epidemiological research
Extended report
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study

 

Online download statistics by month:

Online download statistics by month: November 2017 to March 2024

AbstractFullPdf
Nov 201718481903872
Dec 2017539582239
Jan 2018669682254
Feb 2018460457202
Mar 2018260253221
Apr 2018127127199
May 2018189190182
Jun 201815115485
Jul 2018121121120
Aug 2018139139138
Sep 2018217217218
Oct 2018217217119
Nov 201825225276
Dec 201816616647
Jan 201914314256
Feb 201913113244
Mar 201916216280
Apr 201913012990
May 201913313357
Jun 201911511552
Jul 201911010941
Aug 201918017863
Sep 201912212039
Oct 201913112824
Nov 201910210028
Dec 201911711425
Jan 202013513040
Feb 202011411142
Mar 202012812341
Apr 202012011747
May 2020646223
Jun 2020756833
Jul 2020656343
Aug 20201059838
Sep 202013712775
Oct 2020928581
Nov 2020786721
Dec 20201059821
Jan 2021878145
Feb 2021737042
Mar 2021918336
Apr 2021655827
May 2021817724
Jun 2021827930
Jul 2021898632
Aug 202111311124
Sep 2021746723
Oct 2021857143
Nov 2021767145
Dec 2021949322
Jan 2022948722
Feb 2022686820
Mar 2022817723
Apr 202212311821
May 20221029742
Jun 2022696718
Jul 2022696621
Aug 2022929024
Sep 2022938628
Oct 2022989226
Nov 20221009524
Dec 2022685812
Jan 2023929019
Feb 202312211711
Mar 202312311619
Apr 202311711318
May 202315013615
Jun 202316115927
Jul 202319318228
Aug 202317116520
Sep 202315114833
Oct 202312512137
Nov 2023989328
Dec 202311110520
Jan 202411911634
Feb 202414013529
Mar 20241019262
Total12190120075150